China · Delayed Price · Currency is CNY Jiangsu CoWin Biotech Statistics
Total Valuation
SHA:688426 has a market cap or net worth of CNY 2.05 billion. The enterprise value is 1.34 billion.
| Market Cap | 2.05B |
| Enterprise Value | 1.34B |
Important Dates
The last earnings date was Saturday, October 31, 2026.
| Earnings Date | Oct 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688426 has 109.93 million shares outstanding. The number of shares has decreased by -1.06% in one year.
| Current Share Class | 109.93M |
| Shares Outstanding | 109.93M |
| Shares Change (YoY) | -1.06% |
| Shares Change (QoQ) | +1.21% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 6.77% |
| Float | 35.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.83 |
| PB Ratio | 1.55 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.79, with a Debt / Equity ratio of 0.03.
| Current Ratio | 14.79 |
| Quick Ratio | 13.61 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -447.84 |
Financial Efficiency
Return on equity (ROE) is -6.11% and return on invested capital (ROIC) is -14.82%.
| Return on Equity (ROE) | -6.11% |
| Return on Assets (ROA) | -4.47% |
| Return on Invested Capital (ROIC) | -14.82% |
| Return on Capital Employed (ROCE) | -7.68% |
| Weighted Average Cost of Capital (WACC) | 8.90% |
| Revenue Per Employee | 316,995 |
| Profits Per Employee | -112,128 |
| Employee Count | 732 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.49 |
Taxes
In the past 12 months, SHA:688426 has paid 4.89 million in taxes.
| Income Tax | 4.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.99% in the last 52 weeks. The beta is 0.88, so SHA:688426's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -33.99% |
| 50-Day Moving Average | 20.44 |
| 200-Day Moving Average | 20.68 |
| Relative Strength Index (RSI) | 45.91 |
| Average Volume (20 Days) | 1,717,875 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688426 had revenue of CNY 232.04 million and -82.08 million in losses. Loss per share was -0.75.
| Revenue | 232.04M |
| Gross Profit | 101.16M |
| Operating Income | -90.76M |
| Pretax Income | -78.64M |
| Net Income | -82.08M |
| EBITDA | -58.95M |
| EBIT | -90.76M |
| Loss Per Share | -0.75 |
Balance Sheet
The company has 756.03 million in cash and 43.35 million in debt, with a net cash position of 712.69 million or 6.48 per share.
| Cash & Cash Equivalents | 756.03M |
| Total Debt | 43.35M |
| Net Cash | 712.69M |
| Net Cash Per Share | 6.48 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 11.99 |
| Working Capital | 840.78M |
Cash Flow
In the last 12 months, operating cash flow was -23.96 million and capital expenditures -24.31 million, giving a free cash flow of -48.27 million.
| Operating Cash Flow | -23.96M |
| Capital Expenditures | -24.31M |
| Depreciation & Amortization | 31.81M |
| Net Borrowing | -23.73M |
| Free Cash Flow | -48.27M |
| FCF Per Share | -0.44 |
Margins
Gross margin is 43.60%, with operating and profit margins of -39.12% and -35.37%.
| Gross Margin | 43.60% |
| Operating Margin | -39.12% |
| Pretax Margin | -33.89% |
| Profit Margin | -35.37% |
| EBITDA Margin | -25.41% |
| EBIT Margin | -39.12% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688426 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.06% |
| Shareholder Yield | 1.06% |
| Earnings Yield | -4.01% |
| FCF Yield | -2.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a forward split with a ratio of 1.2000048.
| Last Split Date | Jun 12, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2000048 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |